from UConn Today

The Office of the Vice President for Research (OVPR) recently announced the recipients of the 2022-23 SPARK Technology Commercialization Fund Program.  Five recipients were selected for internal funding through the program. They include researchers from UConn and UConn Health.

SPARK supports innovative proof-of-concept studies seeking to translate research discoveries into products, processes, and other commercial applications. The program’s primary goal is advancing primary faculty inventions toward the market, where they can have a positive impact for UConn, society, and Connecticut’s economy.

The 2022-23 awardees competed for funding in a highly selective process. Congratulations to the following:

Laijun Lai, UConn, Department of Allied Health Sciences
Targeting TAPBPL in antitumor immune therapy

Raman Bahal, UConn, Department of Pharmaceutical Science
Liver- and Kidney-targeted delivery of next generation miRNA inhibitors using carbohydrate-based conjugates

Eugene Pinkhassik, UConn, Department of Chemistry/Institute of Materials Science
Integration of palladium-catalyzed reactions in continuous manufacturing

Ali Tamayol, UConn Health, Department of Biomedical Engineering
Engineering a Handheld One-step Foaming and Printing Device for the Treatment of Soft Tissue Injuries

Luyi Sun, UConn, Department of Chemical and Biomolecular Engineering/Institute of Materials Science
High Performance Nanocoatings for Packaging Applications

For more information about SPARK, visit the program website.

---